Study of the combination therapy of Rt-PA and eptifibatide to treat acute ischemic stroke (CLEAR-ER)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is determine the effects of using of a combination of two drugs--integrilin (eptifibatide) and activase (recombinant tissue plasminogen activator, rt-PA, or recombinant t-PA)--to dissolve blood clots in patients who have a stroke.
Epistemonikos ID: f1b79ed159c02612f71102b7dc44c9cd29e78571
First added on: May 04, 2024